Journal of Alzheimers Disease Reports
Scope & Guideline
Fostering Innovation in Dementia Studies
Introduction
Aims and Scopes
- Pathophysiology and Mechanisms of Alzheimer's Disease:
Research focusing on the underlying biological processes, including amyloid-beta accumulation, tau pathology, neuroinflammation, and neurodegeneration mechanisms. - Diagnosis and Biomarkers:
Studies exploring various diagnostic tools and biomarkers for early detection of Alzheimer's disease, including neuroimaging, cerebrospinal fluid analysis, and blood-based biomarkers. - Therapeutic Interventions:
Investigations into pharmacological and non-pharmacological treatments aimed at mitigating cognitive decline and improving quality of life for Alzheimer's patients. - Cognitive and Behavioral Health:
Research assessing cognitive functions, behavioral symptoms, and psychological factors in individuals with Alzheimer's disease. - Caregiver Support and Community Health:
Explorations of the impact of Alzheimer's on caregivers, community resources, and interventions designed to support those caring for individuals with dementia. - Social Determinants of Health and Health Disparities:
Studies examining the influence of socioeconomic factors, race, and culture on the prevalence and management of Alzheimer's disease.
Trending and Emerging
- Microbiome and Gut-Brain Axis Research:
An increasing number of studies are exploring the relationship between gut health, microbiota, and Alzheimer's disease, indicating a growing interest in how dietary and microbial factors influence cognitive health. - Digital Health and Technology Use:
The use of digital tools, such as telehealth and mobile health applications, for monitoring and supporting cognitive health is becoming more prevalent, reflecting a trend towards integrating technology in dementia care. - Inflammation and Immune Response:
There is a rising focus on the role of neuroinflammation and the immune system in Alzheimer's disease, with research investigating how inflammatory pathways contribute to disease progression. - Lifestyle Interventions and Prevention Strategies:
Research is increasingly emphasizing non-pharmacological interventions, such as physical activity, diet, and social engagement, aimed at preventing cognitive decline and promoting brain health. - Long COVID and Cognitive Impairment:
Recent publications are examining the effects of COVID-19 on cognitive function, particularly in patients with pre-existing dementia or mild cognitive impairment, highlighting an emerging area of concern in the context of the pandemic.
Declining or Waning
- Traditional Pharmacological Approaches:
While pharmacological studies remain important, there has been a noticeable shift towards exploring innovative therapies, including lifestyle interventions and personalized medicine, leading to a decline in traditional drug trials. - Single-Disease Focus:
Research focusing exclusively on Alzheimer's disease as a standalone condition is decreasing. There is a growing trend towards examining comorbidities and the interplay between Alzheimer's and other neurological or systemic diseases. - Solely Genetic Studies:
The focus on genetic predispositions to Alzheimer's disease is waning as researchers increasingly recognize the multifactorial nature of the disease, incorporating environmental and lifestyle factors into their analyses.
Similar Journals
Aging Brain
Advancing Knowledge on Aging and CognitionAging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.
NEUROPSYCHIATRIE
Exploring the Intersection of Mind and BrainNEUROPSYCHIATRIE, published by SPRINGER WIEN, is a prestigious journal operating from Austria that focuses on advancing the fields of Clinical Psychology and Psychiatry. With an ISSN of 0948-6259 and an E-ISSN of 2194-1327, NEUROPSYCHIATRIE has garnered attention within the academic community, exemplified by its classification in the Q2 category for Clinical Psychology and Q3 for Psychiatry and Mental Health as of 2023. The journal provides a platform for the dissemination of innovative research findings and clinical insights, critical for professionals dedicated to addressing complex neuropsychiatric conditions. Researchers aspiring to explore the intricacies of mental health will find a wealth of knowledge, as evidenced by its Scopus rankings—115th in Clinical Psychology and 260th in Psychiatry and Mental Health—indicating its influential position. Covering a wide range of topics from neurobiology to psychotherapeutic interventions, NEUROPSYCHIATRIE acts as a vital resource, making significant contributions to enhancing clinical practices and fostering interdisciplinary collaborations in mental health.
Multiple Sclerosis Journal
Catalyzing Change Through Groundbreaking ResearchMultiple Sclerosis Journal, published by SAGE Publications Ltd, is a leading academic journal in the fields of neurology and clinical neurology, with an impressive impact factor reflecting its critical role in neurological research. Established in 1995 and continuing to 2024, this journal has positioned itself as a premier platform for disseminating innovative and impactful research related to multiple sclerosis, thereby contributing significantly to both clinical practice and scientific advancements in the field. The journal's robust standing is evidenced by its Q1 category rankings, placing it in the top tier of both Neuroscience (Rank #16/192, 91st Percentile) and Clinical Neurology (Rank #35/400, 91st Percentile) categories, making it an essential resource for researchers, healthcare professionals, and students alike. The journal focuses on a wide array of topics, including basic research, clinical trials, and treatment methodologies, ensuring that its readership is well-informed about the latest developments and trends. Access to its articles is through subscription, fostering a reputable environment for quality research dissemination.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Unveiling insights into Alzheimer’s and associated disorders.ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Leading the charge in neurological and psychiatric innovation.JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Bridging gaps in geriatric mental health knowledge.International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.
Frontiers in Aging Neuroscience
Exploring the Neurological Pathways of Aging.Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.
BMC NEUROSCIENCE
Exploring the Frontiers of Neuroscience ResearchBMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.
American Journal of Alzheimers Disease and Other Dementias
Unlocking insights into Alzheimer's and dementia.The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.
NEUROPSYCHOLOGY
Advancing the Science of Mind and BrainNEUROPSYCHOLOGY, published by the American Psychological Association, is a leading journal dedicated to advancing the field of neuropsychology and physiological psychology. With an ISSN of 0894-4105 and an E-ISSN of 1931-1559, the journal has established itself as a critical resource for researchers, clinicians, and students interested in the intersection of neuroscience and psychological practice. Recognized as a Q1 journal in its category for 2023, it holds a prominent position within the top quartile of neuropsychology journals, reflecting its rigorous peer-review process and high-quality publications. Covering a wide spectrum of topics from cognitive functions and brain-behavior relationships to clinical assessments and interventions, NEUROPSYCHOLOGY plays a pivotal role in disseminating significant research findings that enhance our understanding of the brain's complexities. Although this journal does not currently offer Open Access, it remains highly regarded for its contribution to the scientific community, as evidenced by its strong Scopus ranking of #34/76 in neuropsychology. As it marks over three decades of publication from 1990 to 2024, NEUROPSYCHOLOGY continues to be an essential publication for those committed to exploring and improving the field.